Omada Health (NASDAQ:OMDA) CAO Craig Gracey Sells 6,894 Shares

Posted by Brian Himes on Jun 16th, 2026

Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CAO Craig Gracey sold 6,894 shares of Omada Health stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $17.42, for a total value of $120,093.48. Following the completion of the sale, the chief accounting officer owned 9,191 shares of the company’s stock, valued at approximately $160,107.22. The trade was a 42.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Omada Health Stock Down 1.4%

OMDA stock traded down $0.24 during midday trading on Tuesday, reaching $17.09. The stock had a trading volume of 729,778 shares, compared to its average volume of 1,213,043. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92. The business has a fifty day simple moving average of $15.45 and a two-hundred day simple moving average of $14.80. The firm has a market cap of $1.02 billion and a price-to-earnings ratio of -63.30.

Omada Health (NASDAQ:OMDA – Get Free Report) last released its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The firm had revenue of $78.05 million for the quarter. On average, equities analysts predict that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on OMDA shares. BMO Capital Markets cut their target price on Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a research note on Friday, March 6th. Evercore reissued an “outperform” rating and issued a $20.00 target price on shares of Omada Health in a research note on Friday, May 8th. Needham & Company LLC reissued a “buy” rating and issued a $28.00 target price on shares of Omada Health in a research note on Friday, May 8th. JPMorgan Chase & Co. cut their target price on Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a research note on Thursday, March 12th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Omada Health in a research note on Thursday, June 4th. Ten research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Omada Health has an average rating of “Moderate Buy” and a consensus price target of $22.91.

View Our Latest Stock Analysis on OMDA

Institutional Investors Weigh In On Omada Health

Hedge funds have recently modified their holdings of the business. BIT Capital GmbH bought a new stake in Omada Health in the 3rd quarter valued at $13,639,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Omada Health in the 4th quarter valued at $1,222,000. Divisadero Street Capital Management LP bought a new stake in Omada Health in the 3rd quarter valued at $30,510,000. a16z Perennial Management L.P. bought a new stake in Omada Health in the 4th quarter valued at $2,480,000. Finally, Madryn Asset Management LP bought a new stake in Omada Health in the 4th quarter valued at $9,212,000.

Omada Health Company Profile

(Get Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.